ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1778

Differences Between Early and Late Cardiovascular Disease in a Population-Based Cohort of Systemic Lupus Erythematosus Patients

Shivani Garg1, Gaobin Bao2, Mugisha Niyibizi3, Cristina Drenkard4 and S. Sam Lim2, 1Rheumatology, Emory University, Atlanta, GA, 2Medicine, Emory University School of Medicine, Atlanta, GA, 3Emory University, atlanta, GA, 4Emory University School of Medicine, Atlanta, GA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: cardiovascular disease and race/ethnicity, Lupus

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster II: Damage Accrual and Quality of Life

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:  It has long been known that mortality after years of systemic lupus erythematosus (SLE) is often associated with cardiovascular disease (CVD). Recent studies have also observed excess early CVD, even before SLE diagnosis. This is the first population-based study with large numbers of blacks to evaluate early vs. late CVD.  

Methods: The Georgia Lupus Registry (GLR) is a population-based registry of SLE patients living in Atlanta, GA from 2002-04. Patients were validated by meeting ≥4 ACR criteria or 3 ACR criteria with a final diagnosis of SLE by a board certified rheumatologist and were matched to the Georgia Hospital Discharge Database, capturing all hospitalizations throughout the state from 2000 through 2013. CVD related hospitalizations (CVD-H) were identified based on the first 3 admission codes, which included ischemic heart, cerebrovascular, and peripheral vascular diseases. 2 periods were evaluated. The “Early Period” was defined as the period prior to and within the first 2 years after diagnosis. The “Late Period” was defined as the period afterwards. Multivariable logistic regression analyses were performed to explore the independent effect of demographic and disease-related factors on CVD-H.  

Results: 336 incident SLE patients had 34 CVD-H’s during the surveillance period 2000-2013, 16 as Early CVD (6 ischemic heart, 7 cerebrovascular, 3 peripheral vascular) and 18 as Late CVD (4 ischemic heart, 13 cerebrovascular, 1 other vascular). Characteristics of the Early Period were a mean age at SLE and CVD-H of 52.5 and 52.2, respectively. 81.3% were female and 81.3% black. There were less photosensitivity and more serositis, renal disorder, and neurologic disorder in CVD-H compared to other incident patients (data not shown). Multivariable regression analysis showed 30% increased odds of a CVD-H for every 5-year increase in age at SLE diagnosis and over 6-fold increase in odds with neurologic disorder. Characteristics of the Late Period were a mean age at SLE and CVD-H of 40.1 and 45.8, respectively. 100% were female and 94.4% black. There was more renal disorder in CVD-H compared to other incident patients (data not shown). Multivariable regression analysis showed reduced odds (0.22) of a CVD-H with serositis and a nearly 6-fold (5.71) increase in odds with renal disorder. Race was not a factor in either period.

 

Conclusion: In this population-based cohort, there were significant numbers of CVD events, with nearly equal numbers of CVD-H’s in the Early Period compared to the Late Period. Consistent with previous findings, the Early Period is marked by higher risk in those with late onset of disease. The Late Period had more cerebrovascular events. Other manifestations may help identify those at higher risk for CVD-H’s.

 


Disclosure: S. Garg, None; G. Bao, None; M. Niyibizi, None; C. Drenkard, None; S. S. Lim, None.

To cite this abstract in AMA style:

Garg S, Bao G, Niyibizi M, Drenkard C, Lim SS. Differences Between Early and Late Cardiovascular Disease in a Population-Based Cohort of Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/differences-between-early-and-late-cardiovascular-disease-in-a-population-based-cohort-of-systemic-lupus-erythematosus-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differences-between-early-and-late-cardiovascular-disease-in-a-population-based-cohort-of-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology